225 related articles for article (PubMed ID: 11823516)
41. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH
J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455
[TBL] [Abstract][Full Text] [Related]
42. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
[TBL] [Abstract][Full Text] [Related]
43. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
Inman GJ; Allday MJ
J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
[TBL] [Abstract][Full Text] [Related]
44. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
[TBL] [Abstract][Full Text] [Related]
45. Apoptotic molecules in pancreatic carcinoma cell lines.
Ringel B; Ibrahim SM; Köhler H; Ringel J; Koczan D; Liebe S; Löhr M; Thiesen HJ
Ann N Y Acad Sci; 1999 Jun; 880():175-8. PubMed ID: 10415862
[No Abstract] [Full Text] [Related]
46. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
Frost PJ; Butterfield LH; Dissette VB; Economou JS; Bonavida B
J Immunol; 2001 Mar; 166(5):3564-73. PubMed ID: 11207317
[TBL] [Abstract][Full Text] [Related]
47. Human dendritic cells mediate anti-tumor activity against hematopoietic tumor cells without direct contact and Fas/FasL killing pathway.
Ayres FM; Narita M; Takahashi M; Yano T; Liu A; Toba K; Furukawa T; Aizawa Y
Oncol Rep; 2004 May; 11(5):1017-23. PubMed ID: 15069541
[TBL] [Abstract][Full Text] [Related]
48. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
49. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Fanger NA; Maliszewski CR; Schooley K; Griffith TS
J Exp Med; 1999 Oct; 190(8):1155-64. PubMed ID: 10523613
[TBL] [Abstract][Full Text] [Related]
50. Stimulating lymphotoxin beta receptor on the dendritic cells is critical for their homeostasis and expansion.
Wang YG; Kim KD; Wang J; Yu P; Fu YX
J Immunol; 2005 Nov; 175(10):6997-7002. PubMed ID: 16272360
[TBL] [Abstract][Full Text] [Related]
51. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim K; Fisher MJ; Xu SQ; el-Deiry WS
Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
[TBL] [Abstract][Full Text] [Related]
52. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
Kajiwara K; Saito A; Ogata S; Tanihara M
Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
[TBL] [Abstract][Full Text] [Related]
53. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis.
Leverkus M; Walczak H; McLellan A; Fries HW; Terbeck G; Bröcker EB; Kämpgen E
Blood; 2000 Oct; 96(7):2628-31. PubMed ID: 11001921
[TBL] [Abstract][Full Text] [Related]
54. On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.
Cassatella MA
J Leukoc Biol; 2006 Jun; 79(6):1140-9. PubMed ID: 16574768
[TBL] [Abstract][Full Text] [Related]
55. [TNF family (TNF alpha, beta, FasL, CD40L)].
Manago S; Yonehara S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():202-6. PubMed ID: 15861657
[No Abstract] [Full Text] [Related]
56. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
58. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis.
Griffith TS; Anderson RD; Davidson BL; Williams RD; Ratliff TL
J Immunol; 2000 Sep; 165(5):2886-94. PubMed ID: 10946322
[TBL] [Abstract][Full Text] [Related]
59. Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands.
Janjic BM; Kulkarni A; Ferris RL; Vujanovic L; Vujanovic NL
Front Immunol; 2022; 13():837842. PubMed ID: 35392082
[TBL] [Abstract][Full Text] [Related]
60. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
